Literature DB >> 20181932

p38 MAP kinase is necessary for melanoma-mediated regulation of VE-cadherin disassembly.

Payal Khanna1, Tara Yunkunis, Hari S Muddana, Hsin Hsin Peng, Avery August, Cheng Dong.   

Abstract

Vascular endothelial (VE)-cadherin is localized to the endothelial borders and the adherens junctions, which are regulated by changes in mitogen-activated protein (MAP) kinases, GTPases, and intracellular calcium. We previously showed that melanoma cells induce VE-cadherin disassembly through contact with human umbilical vein endothelial cells in coculture. However, the exact mechanism by which melanoma cells signal endothelial cells to induce VE-cadherin junction disassembly is not well understood. In this study, VE-cadherin junction disassembly was further examined under fluorescence microscopy. We found that melanoma-induced VE-cadherin junction disassembly and upregulation of p38 MAP kinase in endothelial cells is regulated by both soluble factors from melanomas, particularly interleukin (IL)-8, IL-6, and IL-1beta, and through vascular cell adhesion molecule-1. Neutralizing melanoma-secreted soluble factors reduced endothelial gap formation. Endothelial cells transfected with MAP kinase kinase 6, a direct activator of p38 MAP kinase, increased VE-cadherin-mediated gap formation, facilitating melanoma transendothelial migration. In contrast, endothelial cells transfected with small-interfering RNA against p38 MAP kinase expression largely prevented melanoma transendothelial migration in Boyden chamber experiments. These findings indicate that p38 MAP kinase proteins regulate VE-cadherin junction disassembly, facilitating melanoma migration across endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20181932      PMCID: PMC2867383          DOI: 10.1152/ajpcell.00242.2009

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  41 in total

1.  In vitro characterization and micromechanics of tumor cell chemotactic protrusion, locomotion, and extravasation.

Authors:  Cheng Dong; Margaret J Slattery; Bradley M Rank; Jun You
Journal:  Ann Biomed Eng       Date:  2002-03       Impact factor: 3.934

Review 2.  Breaking the VE-cadherin bonds.

Authors:  Julie Gavard
Journal:  FEBS Lett       Date:  2008-12-04       Impact factor: 4.124

3.  Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions.

Authors:  Shile Liang; Cheng Dong
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-16       Impact factor: 4.249

4.  Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.

Authors:  Fang Liao; Jacqueline F Doody; Jay Overholser; Bridget Finnerty; Rajiv Bassi; Yan Wu; Elisabetta Dejana; Paul Kussie; Peter Bohlen; Daniel J Hicklin
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

5.  Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.

Authors:  Zoya R Yurkovetsky; John M Kirkwood; Howard D Edington; Adele M Marrangoni; Lyudmila Velikokhatnaya; Matthew T Winans; Elieser Gorelik; Anna E Lokshin
Journal:  Clin Cancer Res       Date:  2007-04-15       Impact factor: 12.531

6.  Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis.

Authors:  Seema Singh; Michelle Varney; Rakesh K Singh
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

7.  The role of p38 map kinase in tumor necrosis factor-induced redistribution of vascular endothelial cadherin and increased endothelial permeability.

Authors:  Fiemu E Nwariaku; Jianping Chang; Xudong Zhu; Zijuan Liu; Steven L Duffy; Nabil H Halaihel; Lance Terada; Richard H Turnage
Journal:  Shock       Date:  2002-07       Impact factor: 3.454

Review 8.  Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player.

Authors:  Dietmar Vestweber; Mark Winderlich; Giuseppe Cagna; Astrid F Nottebaum
Journal:  Trends Cell Biol       Date:  2008-11-17       Impact factor: 20.808

9.  Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta.

Authors:  Miyako Okamoto; Weimin Liu; Yuchun Luo; Aki Tanaka; Xiangna Cai; David A Norris; Charles A Dinarello; Mayumi Fujita
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

10.  Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase.

Authors:  Donna L Cioffi; Timothy M Moore; Jerry Schaack; Judy R Creighton; Dermot M F Cooper; Troy Stevens
Journal:  J Cell Biol       Date:  2002-06-24       Impact factor: 10.539

View more
  13 in total

1.  Thrombomodulin blocks calcineurin inhibitor-induced vascular permeability via inhibition of Src/VE-cadherin axis.

Authors:  T Ikezoe; J Yang; C Nishioka; K Umezawa; A Yokoyama
Journal:  Bone Marrow Transplant       Date:  2016-09-19       Impact factor: 5.483

2.  Caspase-8 modulates physiological and pathological angiogenesis during retina development.

Authors:  Nathalie Tisch; Aida Freire-Valls; Rosario Yerbes; Isidora Paredes; Silvia La Porta; Xiaohong Wang; Rosa Martín-Pérez; Laura Castro; Wendy Wei-Lynn Wong; Leigh Coultas; Boris Strilic; Hermann-Josef Gröne; Thomas Hielscher; Carolin Mogler; Ralf H Adams; Peter Heiduschka; Lena Claesson-Welsh; Massimiliano Mazzone; Abelardo López-Rivas; Thomas Schmidt; Hellmut G Augustin; Carmen Ruiz de Almodovar
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

3.  Integrin β4 signaling promotes mammary tumor cell adhesion to brain microvascular endothelium by inducing ErbB2-mediated secretion of VEGF.

Authors:  Filippo G Giancotti; Bingmei M Fu; Jie Fan; Bin Cai; Min Zeng; Yanyan Hao
Journal:  Ann Biomed Eng       Date:  2011-05-10       Impact factor: 3.934

4.  Melanoma upregulates ICAM-1 expression on endothelial cells through engagement of tumor CD44 with endothelial E-selectin and activation of a PKCα-p38-SP-1 pathway.

Authors:  Pu Zhang; Chris Goodrich; Changliang Fu; Cheng Dong
Journal:  FASEB J       Date:  2014-08-19       Impact factor: 5.191

5.  Heat shock protein 27 activity is linked to endothelial barrier recovery after proinflammatory GPCR-induced disruption.

Authors:  Cara C Rada; Hilda Mejia-Pena; Neil J Grimsey; Isabel Canto Cordova; Joshua Olson; Jacob M Wozniak; David J Gonzalez; Victor Nizet; JoAnn Trejo
Journal:  Sci Signal       Date:  2021-08-31       Impact factor: 8.192

6.  Prolyl Hydroxylase Domain-2 Protein Regulates Lipopolysaccharide-Induced Vascular Inflammation.

Authors:  Qiying Fan; Hua Mao; Liang Xie; Xinchun Pi
Journal:  Am J Pathol       Date:  2018-10-17       Impact factor: 4.307

7.  Mutant B-Raf(V600E) Promotes Melanoma Paracellular Transmigration by Inducing Thrombin-mediated Endothelial Junction Breakdown.

Authors:  Pu Zhang; Shan Feng; Gentao Liu; Heyong Wang; Huifeng Zhu; Qiao Ren; Huiyuan Bai; Changliang Fu; Cheng Dong
Journal:  J Biol Chem       Date:  2015-10-26       Impact factor: 5.157

8.  Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins.

Authors:  Jun Xu; Steve Seung-Young Lee; Howon Seo; Liang Pang; Yearin Jun; Ruo-Yu Zhang; Zhong-Yin Zhang; Pilhan Kim; Wooin Lee; Stephen J Kron; Yoon Yeo
Journal:  Small       Date:  2018-11-09       Impact factor: 13.281

9.  Tara up-regulates E-cadherin transcription by binding to the Trio RhoGEF and inhibiting Rac signaling.

Authors:  Tomoki Yano; Yuji Yamazaki; Makoto Adachi; Katsuya Okawa; Philippe Fort; Masami Uji; Shoichiro Tsukita; Sachiko Tsukita
Journal:  J Cell Biol       Date:  2011-04-11       Impact factor: 10.539

10.  Actinomyosin contraction, phosphorylation of VE-cadherin, and actin remodeling enable melanoma-induced endothelial cell-cell junction disassembly.

Authors:  Eric Weidert; Steven E Pohler; Esther W Gomez; Cheng Dong
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.